Clinical Trials

140 enrolled

Neoplasms, Colorectal Neoplasms

NCT07206056 2026-05-08

TulmiSTAR-01

Phase 1/2 Recruiting

188 enrolled

Progressive Metastatic Castrate Resistant Prostate Cancer

NCT04844866 2026-04-29

DALY 2-EU

LymphoidOther hematologic neoplasm

213 enrolled

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Hematologic Neoplasms

NCT06585410 2026-04-22

Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

Phase 3 Recruiting

369 enrolled

Dermatologic

Skin Neoplasms

NCT07155187 2026-03-11

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Phase 2/3 Recruiting

430 enrolled

Phase 3 Active not recruiting

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT05316701 2026-03-04

Orca-T

187 enrolled 15 charts

LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06855277 2026-02-24

AcTFirst

Phase 3 Recruiting

940 enrolled

Prostatic Neoplasms

NCT04876651 2026-02-20

The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only

Phase 3 Terminated

16 enrolled

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT04485949 2026-02-10

A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma

93 enrolled

CNS

Glioblastoma

NCT05405595 2026-01-07

ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors

Phase 1/2 Recruiting

186 enrolled

Other solid neoplasm

Advanced/Metastatic Solid Tumors

NCT03602859 2025-12-31

FIRST

Phase 3 Active not recruiting

1,400 enrolled 18 charts

Gynecologic

Ovarian Neoplasms

NCT04567420 2025-10-16

DARE

70 enrolled

Phase 3 Not yet recruiting

Breast Neoplasms

NCT07181239 2025-09-18

Study of CM336 in Relapsed or Refractory Multiple Myeloma Patients

280 enrolled

Plasma cell

Multiple Myeloma

NCT03778931 2025-09-15

EMERALD

478 enrolled 16 charts 1 FDA

Breast Neoplasms

NCT07150663 2025-09-08

Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer

Phase 3 Recruiting

134 enrolled

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT05608044 2025-09-04

A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer

234 enrolled

Diabetes Mellitus, Insulin-Dependent, 12, Parkinson Disease 4, Autosomal Dominant Lewy Body, Colorectal Neoplasms

NCT04467593 2025-08-05

MATTERS

16 enrolled

Advanced Cancer

NCT01711671 2025-08-03

A Study of DKN-01 and Lenalidomide/Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Phase 1 Completed

8 enrolled

Plasma cell

Multiple Myeloma

NCT03575351 2025-08-03

TRANSFORM

184 enrolled 30 charts 1 FDA

Lymphoid

Lymphoma, Non-Hodgkin, Recurrence

NCT03194646 2025-07-28

ASTEROID 6

Phase 3 Terminated

1,272 enrolled 16 charts

Leiomyoma

NCT05801965 2025-05-25

A Digital Therapeutic Solution for Cancer Patients

GastrointestinalGenitourinaryThoracic

48 enrolled

Lung Neoplasms, Motor Activity, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Medication Adherence

NCT06989450 2025-05-25

Digital Patient Support Program for Self-efficacy and Medication Adherence in Women on Adjuvant Endocrine Treatment for Breast Cancer

Phase NA Recruiting

140 enrolled

Phase 3 Not yet recruiting

Breast Neoplasms, Neoplasms, Medication Adherence

NCT06961188 2025-05-07

Clinical Study on Nanocrystalline Megestrol Acetate for Appetite Improvement and Weight Gain in Pre-Cachexia and Cachexia Stages Key Terminology Analysis

174 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT06636682 2024-10-21

FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer

100 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT04982627 2024-07-03

BNICHAT

4 enrolled

Lymphoid

Criminal Behavior, Lymphoma, Follicular, Opioid-Related Disorders

NCT04099888 2023-09-11

RELEASE

Phase 2 Terminated

41 enrolled 17 charts

Bile Duct Neoplasms, Cholangiocarcinoma

NCT00556374 2023-07-27

Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy

3,420 enrolled 19 charts

Breast Neoplasms

NCT01468623 2023-07-19

PROFUSE

Phase 4 Terminated

51 enrolled

Neoplasm Metastasis, Colorectal Neoplasms

NCT04733833 2023-02-01

A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19

5 enrolled

Lymphoid

COVID-19, Lymphoma, Follicular

NCT04963972 2022-05-10

Digital and Behavioral Tele-Health Tapering Program for Lowering Dependence on Opioids in Patients Undergoing Surgery

Phase NA Unknown

272 enrolled

Head & Neck

Head and Neck Neoplasms

NCT02107937 2022-05-04

Phase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian Carcinoma

136 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT03329690 2022-03-18

DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Gastric Cancer [DESTINY-Gastric01]

233 enrolled 26 charts 1 FDA

Adenocarcinoma, Gastrointestinal Neoplasms

NCT04446429 2021-12-10

Anti-Androgen Treatment for COVID-19

268 enrolled 8 charts

COVID-19, Alopecia, Prostatic Hyperplasia, Prostatic Neoplasms, Severe Acute Respiratory Syndrome

NCT04572776 2021-11-09

Phase 3 Study to Assess Resiniferatoxin vs Standard of Care for the Treatment of Intractable Cancer Pain

Phase 3 Withdrawn

Cancer Pain, Pain, Pain, Intractable

NCT03393000 2021-07-22

INTACT

Phase 3 Terminated

19 enrolled 8 charts

CNS

Glioblastoma

NCT02448810 2021-05-25

Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer

Phase 2 Terminated

115 enrolled 22 charts

Other hematologic neoplasm

Colorectal Neoplasms

NCT03301597 2021-03-30

LAUNCH

Phase 2 Terminated

146 enrolled

Bacterial Infections, Mycoses, Leukemia, Myeloid, Acute

NCT01883362 2021-03-17

RADIUS

Other hematologic neoplasm

60 enrolled 17 charts

Leukemia, Myeloid, Acute

NCT02039726 2021-02-24

(QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive

Other hematologic neoplasm

367 enrolled 12 charts

Leukemia, Leukemia, Myeloid, Acute

NCT02369874 2021-02-10

EAGLE

736 enrolled 26 charts

Head & Neck

Head and Neck Neoplasms, Recurrence

NCT03255980 2020-12-16

Monocenter, Open Label Clinical Investigation on the Treatment of Radiation Induced Dermatitis With Xonrid®

80 enrolled 9 charts

Radiodermatitis

NCT03323021 2020-11-13

Use of Human Dehydrated Amnion/Chorion (DHACM) Allograft in Partial Nephrectomy

61 enrolled

Kidney Neoplasms

NCT04450160 2020-06-29

AEO

Phase 2 Unknown

80 enrolled

CNS

Glioblastoma, Seizures

NCT02187302 2020-05-28

CRLX101(NLG207) in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC)

115 enrolled

Carcinoma, Renal Cell

NCT03472053 2020-05-19

A Study of BIO-11006 in the Treatment of Advanced Non-Small Cell Lung Cancer

60 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT03831633 2019-02-06

Comparative Effectiveness of AKYNZEO® and Standard of Care (Including EMEND®) for the Prevention of Nausea and Vomiting (CINV) in Cancer Patients

Phase 4 Unknown

426 enrolled

Tumor-Agnostic

Neoplasms

NCT02200081 2018-11-15

IMPULSE

103 enrolled

Small Cell Lung Carcinoma

NCT02107950 2018-08-15

Phase II Study DCVAC/OvCa Plus Carboplatin Gemcitabine Relapsed Platinum (Pt)-Sensitive Epithelial Ovarian Carcinoma